← All indications

Sirolimus

A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.

Subtype terms (1)

More specific conditions that are subtypes of Sirolimus in the MeSH hierarchy.

Drugs by status

Phase 1 trials (1)